Starpharma Current ratio
Что обозначает Current ratio в Starpharma?
Current ratio Starpharma Holdings Limited является 4.94
Какое определение для Current ratio?
Коэффициент текущей ликвидности - это коэффициент ликвидности, который измеряет, достаточно ли у компании ресурсов для выполнения своих краткосрочных обязательств.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio компаний в Health Care сектор на ASX по сравнению с Starpharma
Что делает Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Компании с current ratio похож на Starpharma
- Tristel Plc имеет Current ratio из 4.93
- Musgrave Minerals имеет Current ratio из 4.93
- The Mandhana Retail Ventures имеет Current ratio из 4.93
- ACON S2 Acquisition имеет Current ratio из 4.93
- Tamawood имеет Current ratio из 4.93
- Vitreous Glass имеет Current ratio из 4.93
- Starpharma имеет Current ratio из 4.94
- Civitas Social Housing Plc имеет Current ratio из 4.94
- China Outfitters имеет Current ratio из 4.95
- Uranium Participation имеет Current ratio из 4.95
- Uranium Participation имеет Current ratio из 4.95
- NexPoint Residential Trust Inc имеет Current ratio из 4.95
- CARE Ratings имеет Current ratio из 4.95